Browse by Journal Title

2023

Retinal ganglion cell loss is associated with future disability worsening in early relapsing remitting multiple sclerosis.
Wauschkuhn, J. and Solorza Buenrostro, G. and Aly, L. and Asseyer, S. and Wicklein, R. and Hartberger, J.M. and Ruprecht, K. and Mühlau, M. and Schmitz-Hübsch, T. and Chien, C. and Berthele, A. and Brandt, A.U. and Korn, T. and Paul, F. and Hemmer, B. and Zimmermann, H.G. and Knier, B.
European Journal of Neurology 30 (4): 982-990. April 2023

Early spinal cord pseudoatrophy in interferon-beta treated multiple sclerosis.
Matusche, B. and Litvin, L. and Schneider, R. and Bellenberg, B. and Mühlau, M. and Pongratz, V. and Berthele, A. and Groppa, S. and Muthuraman, M. and Zipp, F. and Paul, F. and Wiendl, H. and Meuth, S.G. and Sämann, P. and Weber, F. and Linker, R.A. and Kümpfel, T. and Gold, R. and Lukas, C.
European Journal of Neurology 30 (2): 453-462. February 2023

2022

Diagnostic accuracy of cerebrospinal fluid biomarkers for the differential diagnosis of sporadic Creutzfeldt-Jakob disease: a (network) meta-analysis.
Rübsamen, N. and Pape, S. and Konigorski, S. and Zapf, A. and Rücker, G. and Karch, A.
European Journal of Neurology 29 (5): 1366-1376. May 2022

Retinoids are not linked to risk of multiple sclerosis: a Danish nationwide cohort study.
Cortes-Figueiredo, F. and Nielsen, N.M. and Stenager, E. and Paul, F. and Hallas, J. and Kristensen, K.B.
European Journal of Neurology 2 (1): 247-256. 18 January 2022

2021

Foveal changes in aquaporin‐4 antibody seropositive neuromyelitis optica spectrum disorder are independent of optic neuritis and not overtly progressive.
Roca-Fernández, A. and Oertel, F.C. and Yeo, T and Motamedi, S. and Probert, F. and Craner, M.J. and Sastre-Garriga, J. and Zimmermann, H.G. and Asseyer, S. and Kuchling, J. and Bellmann-Strobl, J. and Ruprecht, K. and Leite, M.I. and Paul, F. and Brandt, A.U. and Palace, J.
European Journal of Neurology 28 (7): 2280-2293. July 2021

Pain, depression and quality of life in adults with MOG-antibody associated disease.
Asseyer, S. and Henke, E. and Trebst, C. and Hümmert, M.W. and Wildemann, B. and Jarius, S. and Ringelstein, M. and Aktas, O. and Pawlitzki, M. and Korsen, M. and Klotz, L. and Siebert, N. and Ruprecht, K. and Bellmann-Strobl, J. and Wernecke, K.D. and Häußler, V. and Havla, J. and Gahlen, A. and Gold, R. and Paul, F. and Kleiter, I. and Ayzenberg, I.
European Journal of Neurology 28 (5): 1645-1658. May 2021

2020

Emotional experience in patients with clinically isolated syndrome and early multiple sclerosis.
Hälbig, T.D. and Wüstenberg, T. and Giess, R.M. and Kunte, H. and Bellmann-Strobl, J. and Ruprecht, K. and Paul, F.
European Journal of Neurology 27 (8): 1537-1545. August 2020

2016

Low 25-hydroxyvitamin D, but not the bioavailable fraction of 25-hydroxyvitamin D, is a risk factor for multiple sclerosis.
Behrens, J.R. and Rasche, L. and Giess, R.M. and Pfuhl, C. and Wakonig, K. and Freitag, E. and Deuschle, K. and Bellmann-Strobl, J. and Paul, F. and Ruprecht, K. and Doerr, J.
European Journal of Neurology 23 (1): 62-67. January 2016

2015

Optical coherence tomography in patients with a history of juvenile multiple sclerosis reveals early retinal damage.
Huhn, K. and Lämmer, R. and Oberwahrenbrock, T. and Lämmer, A. and Waschbisch, A. and Gosar, D. and Brandt, A. and Paul, F. and Linker, R.A. and Lee, D.H.
European Journal of Neurology 22 (1): 86-92. January 2015

2013

Optical coherence tomography does not support optic nerve involvement in amyotrophic lateral sclerosis.
Roth, N.M. and Saidha, S. and Zimmermann, H. and Brandt, A.U. and Oberwahrenbrock, T. and Maragakis, N.J. and Tumani, H. and Ludolph, A.C. and Meyer, T. and Calabresi, P.A. and Paul, F.
European Journal of Neurology 20 (8): 1170-1176. August 2013

Loss of retinal nerve fibre layer axons indicates white but not grey matter damage in early multiple sclerosis.
Young, K.L. and Brandt, A.U. and Petzold, A. and Reitz, L.Y. and Lintze, F. and Paul, F. and Martin, R. and Schippling, S.
European Journal of Neurology 20 (5): 803-811. May 2013

2010

A novel MRI-biomarker candidate for Alzheimer's disease composed of regional brain volume and perfusion variables.
Luckhaus, C. and Jaenner, M. and Cohnen, M. and Fluess, M.O. and Teipel, S.J. and Grothe, M. and Hampel, H. and Kornhuber, J. and Ruether, E. and Peters, O. and Supprian, T. and Gaebel, W. and Moedder, U. and Wittsack, H.J.
European Journal of Neurology 17 (12): 1437-1444. December 2010